文献速递慢阻肺

慢性肺病患者肌少症风险分层模型的开发与验证:基于CHARLS数据的横断面研究

Development and validation of a risk stratification model for sarcopenia in patients with chronic lung disease: a cross-sectional study based on CHARLS data
RSS 订阅 · BMJ Open Respiratory Research

基于CHARLS数据中1833例慢性肺病患者(肌少症388例,非肌少症1445例),采用LASSO回归筛选变量并用六种机器学习算法构建肌少症风险分层模型,其中XGBoost在测试集AUC最高(0.93),腰围、年龄和性别为最重要预测因子。

要点

  • 六种机器学习算法在训练集和测试集均表现优异,XGBoost整体性能最高(AUC=0.93)。
  • 腰围、年龄和性别是慢性肺病患者肌少症的三个最重要预测因子。
  • 该可解释模型可能作为临床工具支持早期个性化干预。

核心结论

  • 本研究开发了可解释的机器学习风险分层模型,用于识别慢性肺病患者中的肌少症高风险个体,可能作为支持早期个性化干预的新临床工具。

研究设计与样本

  • 横断面研究,纳入CHARLS数据集中1833例慢性肺病患者完整记录,其中肌少症388例、非肌少症1445例,收集17个变量,按7:3分为训练集和测试集,采用LASSO回归筛选变量并用六种机器学习算法构建模型,通过时间验证(n=1205)和SHAP分析确保稳健性和可解释性。

主要发现

  • 六种机器学习算法在训练集和测试集均表现优异(ROC曲线分析),其中XGBoost整体性能最高(AUC=0.93)。
  • 特征重要性分析显示腰围、年龄和性别是慢性肺病患者肌少症的三个最重要预测因子。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective The aim of this study was to develop a machine learning-based stratification model to identify high-risk individuals for sarcopenia among patients with chronic lung disease (CLD), thereby facilitating early personalised management of this complication. Methods We included 1833 complete patient records with CLD diagnoses from the China Health and Retirement Longitudinal Study dataset, comprising 388 sarcopenia cases and 1445 non-sarcopenia controls. 17 variables were collected, including demographic characteristics (age, gender, waist circumference, education level), lifestyle factors and chronic comorbidities. Data were split into training and test sets (7:3 ratio). Variables were screened using Least Absolute Shrinkage and Selection Operator (LASSO) regression, and six machine learning algorithms were employed to construct and validate stratification models, with performance evaluated through multiple metrics. Temporal validation (n=1205) and SHapley Additive exPlanations analysis ensured robustness and interpretability. Results All six machine learning algorithms demonstrated excellent performance in both the training and test sets, as evidenced by receiver operating characteristic curve analysis. Among them, eXtreme Gradient Boosting achieved the highest overall performance (area under the curve=0.93). The feature importance analysis identified waist circumference, age and gender as the three most significant predictors of sarcopenia in patients with CLD. Conclusions This study developed an interpretable machine learning-based risk stratification model for sarcopenia in patients with CLD. The model may serve as a novel clinical tool to support early personalised interventions and improve patient prognosis.

来源:BMJ Open Respiratory Research,查看原文。版权归原作者所有。

引用

  1. BMJ Open Respiratory Research:Development and validation of a risk stratification model for sarcopenia in patients with chronic lung disease: a cross-sectional study based on CHARLS data

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。